L. N. Petrov

Frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: results from the European ENEST1st study

Andreas Hochhaus, Gianantonio Rosti, Nicholas C.P. Cross et al. · Leukemia · 2015 · 105 citations · Full text

Hepatitis B and C virus infection in Romanian non‐Hodgkin's lymphoma patients

Andrei Cucuianu, Mariana Paţiu, Milena Duma et al. · British Journal of Haematology · 1999 · 75 citations · Full text

<i><scp>TERT</scp></i> rs2736100 A&gt;C <scp>SNP</scp> and <i><scp>JAK</scp>2</i> 46/1 haplotype significantly contribute to the occurrence of <i><scp>JAK</scp>2</i> V617F and <i><scp>CALR</scp></i> mutated myeloproliferative neoplasms – a multicentric study on 529 patients

Adrian P. Trifa, Claudia Bănescu, Mihaela Tevet et al. · British Journal of Haematology · 2016 · 34 citations

The G allele of the JAK2 rs10974944 SNP, part of JAK2 46/1 haplotype, is strongly associated with JAK2 V617F-positive myeloproliferative neoplasms

Adrian P. Trifa, Andrei Cucuianu, L. N. Petrov et al. · Annals of Hematology · 2010 · 30 citations · Full text

Hematological Malignancy, G Allele, Jak2 46/1 +9

Impact of age on efficacy and toxicity of nilotinib in patients with chronic myeloid leukemia in chronic phase: ENEST1st subanalysis

Francis J. Giles, Delphine Réa, Gianantonio Rosti et al. · Journal of Cancer Research and Clinical Oncology · 2017 · 30 citations · Full text